The latest closing stock price for Inhibikase Therapeutics as of April 25, 2025 is 2.11.
An investor who bought $1,000 worth of Inhibikase Therapeutics stock at the IPO in 2020 would have $-964 today, roughly -1 times their original investment - a -56.59% compound annual growth rate over 4 years.
The all-time high Inhibikase Therapeutics stock closing price was 59.40 on December 23, 2020.
The Inhibikase Therapeutics 52-week high stock price is 4.20, which is 99.1% above the current share price.
The Inhibikase Therapeutics 52-week low stock price is 1.12, which is 46.9% below the current share price.
The average Inhibikase Therapeutics stock price for the last 52 weeks is 2.00.